{HEAD ~ The present invention} relates to novel compounds that are partial or full A1 adenosine receptor agonists, and to {TAIL ~ their use} in treating mammals for various disease states, including cardiovascular diseases, in particular arrhythmia, and the prevention of sudden death resulting from arrhythmia, ischemia, CNS disorders including pain, epilepsy, emesis, and metabolic disorders including diabetes and obesity 
relates to
{ HEAD ~ The present invention } relates to novel compounds that are partial or full A1 adenosine receptor agonists , and to { TAIL ~ their use } in treating mammals for various disease states , including cardiovascular diseases , in particular arrhythmia , and the prevention of sudden death resulting from arrhythmia , ischemia , CNS disorders including pain , epilepsy , emesis , and metabolic disorders including diabetes and obesity
HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH